Choose Your Own Adventure
Global equities looked to kick off the second quarter with gains as market participants weighed the ramifications of Joe Biden's $2.25 trillion infrastructure plan.
Pfizer released long-term followup data from a phase 3 vaccine trial showing its shot exhibited 91% efficacy after six months. Notably, the company said that in South Africa, where the B.1.351 lineage is prevalent, and 800 participants were enrolled, all nine observed cases of COVID-19 were in the placebo group.
"In an exploratory
“Notably, the company said that in South Africa, where the B.1.351 lineage is prevalent, and 800 participants were enrolled, all nine observed cases of COVID-19 were in the placebo group.”
A bit off-topic, but if I was in the placebo group, I would want to know that by now and would think I was entitled to the vaccine!